TrialDiabetes, obesity & metabolism2019

Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10).

Kirstine Brown-Frandsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.